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doi:10.1016/j.jtcvs.2007.12.044Objective: The purposes of this study were to identify the occurrence of fibrillin-1
gene polymorphisms or mutations in exons 24 to 28 and to identify the relationship
between ‘‘DNA sequence variants’’ and aortic dilatation in the presence of abnormal
aortic histopathology and other variables in patients undergoing intracardiac repair of
tetralogy of Fallot.
Methods:Operatively excised full-thickness aortic wall tissue and 5 to 10-mL venous
blood samples from 74 consecutive patients undergoing intracardiac repair of tetral-
ogy of Fallot were studied. Histopathologic evaluation was done by light microscopy.
Polymerase chain reaction amplification of fibrillin-1 gene was carried out for 5 exons
(24–28), and amplified products were subjected to single-strand conformation poly-
morphism analysis to identify sequence alterations, if any. Logistic regression analy-
sis was done to identify the relationship between patients with and without ‘‘exonic
DNA variants’’ with other risk factors causing aortic dilatation.
Results: Sixteen aortic tissue specimens (21.6%) were indicated as histologically
normal and used as controls. Of 51 patients with dilated aorta, 48 (94.1%) exhibited
histologic abnormalities. The incidences of significant lamellar loss, abnormal histo-
pathology, and fibrillin-1 ‘‘DNA sequence variants’’ in tetralogy of Fallot with dilated
aorta were 78.4%, 96.1%, and 50.9%, respectively. The risk of aortic dilatation was
8.83 (1.94–13.99) times greater in patients with histologically abnormal aorta and
8.11 (1.93–34.04) times greater in patients with fibrillin-1 ‘‘exonic DNA variants.’’
Conclusion: Our findings indicate the existence of ‘‘exonic DNA variants’’ involving
the fibrillin-1 gene in 1 or more exons (exon 24–28). The ‘‘DNA sequence variants’’
are more pronounced in patients with tetralogy of Fallot and dilated aorta in the pres-
ence of abnormal aortic histopathology.
A
lthough aortic root dilatation has been reported in patients with tetralogy of
Fallot (TOF) even after reparative surgery, its pathophysiology remains
elusive.1-4 It is hypothesized that medial abnormality coupled with increased
aortic blood flow might be the cause for aortic root dilatation in untreated patients.4-9
In our earlier publication, we demonstrated the occurrence of marked histopatholo-
logic changes, ranging from loss and fragmentation of elastic lamellae, increased
accumulation of ground substance, medionecrosis, and fibrosis in the aortic media
of ascending aorta of patients undergoing intercardiac repair of TOF. These changes
were present in infancy and more pronounced in older patients subjected to longstand-
ing cyanosis and volume overload.10
These histopathologic changes resemble those observed in both bicuspid aortic
valve disease and Marfan syndrome.11,12 The genetic basis of Marfan disease has re-
cently been classified, with mutations of the fibrillin-1 genes being responsible forThe Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 3 757
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DAbbreviations and Acronyms
CI 5 confidence interval
DORV 5 double outlet right ventricle
MAPCA 5 major aortopulmonary collateral artery
OR 5 odds ratio
PCR 5 polymerase chain reaction
ROC 5 receiver operating characteristic
SSCP 5 single-strand conformation polymorphism
TOF 5 tetralogy of Fallot
most cases. Fibrillin-1 gene is preferentially found in elastic
tissue (eg, tunica media of the aorta), and defects in its ex-
pression are also implicated in other fibrinopathies.13-16
The fibrillin-1 gene mutations in Marfan syndrome are nor-
mally clustered in the region of exons 24 to 28.13-16
Because of the similarity of histopathologic changes of the
aortic media of patients with TOF, bicuspid aortic valvular
disease, and other fibrinopathies, and the implication of fibril-
lin-1 gene inMarfan syndrome, we hypothesized that fibrillin-
1 gene polymorphisms and mutations may have a biologically
plausible role in the development of dilated aortas in patients
with TOF.4,6-16 We focused our search for fibrillin-1 gene
polymorphisms and mutations on exons 24 to 28 on the basis
that most of the fibrillin-1 gene mutations in Marfan syn-
drome are normally clustered to these 5 exons.
With this background, we conducted this study to i) iden-
tify the prevalence of fibrillin-1 gene polymorphisms or
mutations, if any, in exons 24 to 28 (the region of clustering
of mutations in Marfan syndrome) among patients with TOF
undergoing intracardiac repair; ii) elucidate the histopathology
of the aortic wall in patients with TOF and identify the histo-
pathologic characteristics and other risk factors that may pre-
dispose patients to a higher risk of aortic dilatation seen in
these patients; and iii) identify the relationship among gene
polymorphisms, mutations, and aortic dilatation in the pres-
ence of abnormal aortic histopathology and other variables.
Patients and Methods
Patient Selection Criteria
The study was approved by the institutional review board of the All
India Institute of Medical Sciences, New Delhi, India, and patients
with TOF were enrolled according to the guidelines established by
the institutional ethics committee for human subject research.
In our earlier publication, we addressed the histopathologic find-
ings of the aortic wall of the same patient population undergoing in-
tracardiac repair of TOF and analyzed the risk factors related to
abnormal histopathology and aortic dilatation.10 To test our postu-
lates, we embarked on a program of fibrillin-1 gene mutational/poly-
morphism analysis on patients undergoing intracardiac repair of
TOF between January of 2004 and June of 2006. All patients with
TOF, regardless of age, sex, or race, were approached to participate
in the protocol. The patients were entered in the study protocol after758 The Journal of Thoracic and Cardiovascular Surgery c Sepinformed consent for genetic investigations and aortic wall biopsy
had been obtained from their parents or guardians.
In this study, we have attempted to analyze specifically the rela-
tionship of genetic defect involving the fibrillin-1 gene with aortic
dilatation in the presence of abnormal aortic histopathology and
other candidate variables. The postoperative outcome of these pa-
tients and the findings of risk factor analyses are not repeated here.
All operations in this study population were performed by a sin-
gle surgeon (U.K.C.), maintaining uniformity in the study protocol.
Thus, of 108 consecutive patients undergoing intracardiac repair of
TOF, 89 consented to genetic investigations and were enrolled pro-
spectively into the study. All subjects were tested for 22q11 deletion
by fluorescence in situ hybridization. Patients with a 22q11 deletion
(n 5 9) and trisomy 21 (n 5 6) were excluded from the present
study.17,18
Venous blood samples from these 74 patients (52 male) were ob-
tained for genetic studies, and specimens of the aortic wall from
these 74 patients were also subjected to histopathologic analysis.
Patient Characteristics
Age at correction was 6 months to 45 years (mean, 112.66 104.52;
median, 80 months), with 28.4% of patients (n5 21) aged less than
4 years and 27% of patients (n5 20) aged more than 12 years. Car-
diac catheterization and angiocardiography were performed in all
patients to confirm the diagnosis, define coronary artery anatomy,
and identify major aortopulmonary collateral arteries (MAPCAs).
Aortic diameter measured echocardiographically in our study
showed significant dilatation in 68.9% of patients (n 5 51) with
TOF. Aortic dilatation was defined as the ratio of observed to
expected aortic root diameter index to body surface area and age
greater than 1.5.19 The demographic and clinical characteristics of
patients with normal (n5 23) and dilated aorta (n5 51) in this study
population are shown in Tables E1 and E2. Of 51 patients with
aortic dilatation, 31 (60.7%) were aged more than 96 months, 44
(86.2%) were male, 37 (72.5%) had an SAO2 less than 80% and
hematocrit greater than 45%, 40 (78.4%) had aortic override greater
than 50%, 12 (23.5%) had aortic regurgitation, 27 (52.9%) demon-
strated the presence of MAPCAs, 19 (37.2%) had right aortic arch,
20 (39.2%) had a TOF diagnosis with pulmonary stenosis, and 31
(60.7%) had a double outlet right ventricle (DORV) or TOF with
pulmonary atresia diagnosis (Table E2).
Our study illustrates that the clinical characteristics of the pa-
tients with normal and dilated aortas, including age and other vari-
ables, are not similar. Of 51 patients with aortic dilatation, 49 (96%)
exhibited histologic abnormalities and 26 (50.9%) exhibited fibril-
lin-I ‘‘DNA sequence variants’’ in 1 or more chromosomes (exons
25–28). To identify the relationship between fibrillin-1 genetic poly-
morphisms and mutations and aortic dilatation, a multivariate logis-
tic regression model was used with adjustment for all the variables,
including age and abnormal aortic histopathology (Tables E1–E5).
Standard cardiopulmonary bypass and myocardial protection
techniques were used in all patients. Intracardiac repair was per-
formed with a transatrial, transpulmonary approach in 58 patients
(78.4%) and a trans-right atrial approach in 16 patients (21.6%).
There were 3 perioperative deaths (4%) caused by massive
pulmonary bleeding (n 5 2) and low cardiac output syndrome and
multiorgan failure (n 5 1). There were no late deaths. The details
of the postoperative course and follow-up of these patients have
been addressed in our earlier publication.10tember 2008
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Approximately 5 to 10 mL of venous blood samples were obtained in
ethylenediamine tetraacetic acid tubes for genetic studies. Genomic
DNA was extracted using conventional phenol-chloroform method.
Collection and Preparation of Tissues
The aortic tissues studied were operatively excised from the aortic
cannulation site. A button of full-thickness aortic wall tissue (2–
3mm in width) was excised fromwithin the aortic pursestring suture
on a side-biting aortic clamp as atraumatically as possible. Excised
full-thickness aortic wall tissue during intracardiac repair was
subjected to histopathologic evaluation by light microscopy.
Light Microscopy Evaluation
Each biopsy specimen was fixed in 10% buffered formalin solution
at room temperature and embedded in paraffin block, and thin
sections of 4 to 5 mm were taken. The slides were then stained
with hematoxylin-eosin. Special stains, such as Masson’s trichrome,
elastic Verhoeff Van Gieson, and Alcian blue Periodic Acid Schiff,
were used as and when indicated. The sections were examined with
a research light microscope (Nikon Optiphot, Nikon Corporation,
Tokyo, Japan, magnification 403, 1003, or 2003).
The histopathology slides were simultaneously evaluated by 2 in-
dependent observers, and there was no interobserver disagreement or
interpretation of the presence and absence of disease. The histologic
evaluation of the aortic media included 6 variables: 1) lamellar count,
2) loss or fragmentation of elastic lamellae, 3) increased amount of
ground substance, 4) medionecrosis, 5) smooth muscle disarray
(changes in smooth muscle orientation), and 6) fibrosis. The lesions
were graded 1 to 3 according to the criteria adapted from de Sa and
associates11 and Schlatmann and Becker20 (Table E6).
The grades were determined on the basis of the worst area ob-
served in each specimen. The number of elastic lamellae was
counted at the thickest and thinnest areas in the media, and the
mean of these numbers was calculated. The longer elastic lamellae
parallel to the lumen were included while counting.
Molecular Genetic Studies
Polymerase chain reaction amplification and single-strand
conformation polymorphism analysis. Polymerase chain reaction
(PCR) was carried out with 100 ng of genomic DNA. The coding
region of fibrillin-1 gene, including exon-intron boundaries, was
amplified for 5 exons (24–28) using previously published primers
(Table E7).21
To identify theknownandunknown ‘‘DNAsequencevariants,’’ the
amplified products were subjected to single-strand conformation poly-
morphism (SSCP) analysis for 5 exons of fibrillin-1 gene on 74 patients
undergoing intracardiac repair of TOF and on 52 normal patients from
the general population using the modified method (Table E8).21-23
Among 74 patients undergoing intracardiac repair of TOF, 16
(21.6%) did not exhibit any histologic abnormalities and were
used as the control group. These 16 control subjects contributed
32 reference alleles to the analysis. To determine the prevalence
of fibrillin-1 ‘‘DNA sequence variants’’ in the general population,
we performed SSCP analysis on 52 subjects from the normal popu-
lation, thus contributing 104 reference alleles for data analysis.
All the samples exhibiting shifts were sequenced along with 16
randomly selected samples with no shifts using a commerciallyThe Journal of Thoavailable automatic sequencer (ABI 3700,Macrogen, Seoul, Korea).
The sequencing results were compared with the original data using
NCBI BLAST (Gen Bank Accession No. AC022467 and AC
084757).
Definitions
Aortic root dilatation. Age, height, body weight, and sex are
known to be the determinants of aortic root dimensions in the
normal heart.24,25 Therefore, we used the standard normogram for
aortic root size at the sinotubular junction adopted from Roman
and associates,25 indexed to body surface area and age.19,24 Aortic
root dilatation was defined as the ratio of observed to expected aortic
root diameter greater than 1.5.24,25
Apoptosis. Apoptosis is defined as a form of programmed cell
death and has been recognized as a central feature of fundamental
biological processes, including embryonic morphogenesis, remod-
eling of mature tissues, and cell replacement in certain adult tissues
(eg, the thymus). In contrast with necrosis, apoptosis occurs in iso-
lated cells without any accompanying cellular reaction.26
Elastic fragmentation. Elastic fragmentation is defined as focal
fragmentation of elastic lamellae in the aortic media. Three grades
were recognized: grade 1: fewer than 5 foci of elastic lamellae, loss
or fragmentation in 1 microscopic field, each focus comprising 2 to
4 neighboring elastic lamellae; grade 2: 5 to 9 foci of elastic lamellae
fragmentation in 1 microscopic field; grade 3: presence of 10 or
more foci of elastic fragmentation in 1 microscopic field (Table E6).
Accumulation of ground substance. The ground substance is
a hydrated gel composed of glycosaminoglycans, proteoglycans,
and adhesive glycoproteins in which elastic fibers and collagen
are embedded.11,20 Accumulation of ground substance was charac-
terized by a noninflammatory loss of smooth muscle cells in the
presence of intact elastic lamellae and fragmented elastic fibers.
There was mucoid degeneration with no identifiable cystic wall.
In grade 1, there was mild fragmentation of elastic fibers with
a mild increase in ground substance and little or no change in smooth
muscle. In grade 2, there was widespread elastic fiber fragmentation,
further increase in ground substance, and widespread loss of smooth
muscle. In grade 3, there were large areas of complete loss of elastic
fibers and smooth muscle, and large areas of ground substance accu-
mulation (Table E6).11,20
Medionecrosis. Medionecrosis is defined as a focal loss of
smooth muscle nuclei in the media. Three grades were recognized
(Table E6).
Smooth muscle disarray (changes in smooth muscle orienta-
tion). Three grades were recognized: grade 1: smooth muscle disar-
ray involving less than one third of the thickness of the media; grade
2: smooth muscle disarray involving one third to one half of the
thickness of the media; grade 3: large area of smooth muscle disar-
ray involving more than one half of media thickness, associated with
elastic fragmentation (Table E6).
Fibrosis. Fibrosis is defined as an increase in interstitial colla-
gen. Three grades were recognized (Table E6).
DNA sequence variants. The term refers to any changes in the
DNA sequence observed in cases (in this study, patients with TOF
and enlarged aortas) and control subjects.
Genetic polymorphisms. The term refers to the simultaneous oc-
currence in the population of genomes showing allelic variations.
Any site at which multiple alleles exist as stable components ofracic and Cardiovascular Surgery c Volume 136, Number 3 759
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fined as polymorphic if it is present at a frequency of more than 1%
in the population.23
Mutations. Mutations have been defined as DNA sequence
variants that were seen in cases (in this case, patients with TOF
and enlarged aortas) but not among controls. The term ‘‘mutation’’
indeed has more functional implications or at least is not present in
the general population. Point mutations are changes involving single
base pairs. Frameshift mutations arise by deletions or insertions that
are not a multiple of 3 base pairs; they change the frame in which
triplets are translated into protein.23
Polymerase chain reaction. PCR describes a technique in which
cycles of denaturation, annealing with primer, and extension with
DNApolymerase are used to amplify the number of copies of a target
DNA sequence by more than 106 times.21-23
Shift on single-strand conformation polymorphism. In this
study, genetic shift means the actual shift or mobility change of
the PCR product observed during SSCP analysis. A truly genetic
shift has more population-based implications and was not evaluated
in this study.23
Single-strand conformation polymorphism analysis. This is
the simplest, easiest, and most commonly used method for screening
small fragments (200–400 base pairs) of DNA. Because SSCP allows
one to initially screen small fragments of DNA, one can rapidly
screen a larger number of samples for potential sequence alterations.
Identification of a few samples with base pair changes thus allows one
to concentrate sequencing efforts on the most important specimens.
SSCP analysis basically involves separation of PCR strands on
a nondenaturing polyacrylamide gel. Double-stranded DNA is dena-
tured, and single-stranded DNA is seen on the nondenaturing
polyacrylamide gel. As the strands migrate through the gel, they
assume their normal conformation and migrate at different rates pro-
ducing 2 distinct bands. Alterations in base sequence forces the in-
dividual strands to assume a somewhat different conformation, and
this results in a diagnostic ‘‘band shift’’ or ‘‘change of mobility’’ of 1
or both fragments. These samples are sequenced to identify the
changes in base sequence in the DNA. Fragments can be visualized
by either end labeling the primers with p32 or using sensitive dyes in
a radioactive free ‘‘cold SSCP.’’21-23
Statistical Methods and Analysis
Statistical analysis was performed with Intercooled STATA 9.0
Software (College Station, Tex). Interval-related data were
expressed as mean 6 standard deviation, and categoric variables
were expressed as percentages. The difference in proportions was
tested using the chi-square test.
The receiver operating characteristic (ROC) analysis was per-
formed to determine the cutoff value of the lamellar count, which
will predictably separate normal from the abnormal considering aor-
tic dilatation as the outcome and taking histopathology as the gold
standard. To quantify the predictive accuracy of the lamellar count,
the area under the ROC curve was analyzed (Figure 1).
Aortic tissue specimens without histologic abnormalities were
defined as normal and used as normal controls. The simple logistic
regression followed by forward stepwise multiple logistic regression
analysis was used to identify the independent risk factors associated
with the diseased pathology and aortic dilatation. Subsequently,
stepwise forward logistic regression analysis was performed to iden-
tify the relationship, if any, between patients with and without ‘‘ex-760 The Journal of Thoracic and Cardiovascular Surgery c Seponic DNA sequence variants’’ with other risk factors causing aortic
dilatation, including abnormal histopathology.
The non-encoding regions of the genome (intronic) variants were
considered as biologically insignificant in causing the disease and
were excluded from data analysis. Therefore, DNA sequence vari-
ants from encoding regions (exons only) were considered for statis-
tical analysis. The results were expressed as odds ratio (OR) and
95% confidence interval (CI) for each independent variable.
Results
Histopathology and Risk Factor Analysis
Sixteen aortic tissue specimens (21.6%) were found to be
histologically normal and used as controls. These specimens
exhibited layers of longitudinally arranged elastic lamellae
interspersed with smooth muscle cells and collagen fibrils
in a mucopolysaccharide ground substance.
Elastic fragmentation, increased ground substance, medio-
necrosis, smooth muscle disarray, and fibrosis were present in
58 (78.4%), 43 (58.1%), 37 (36.5%), 27 (36.5%), and 45
(60.8%) specimens, respectively (Table E3). Because both
the pathologists agreed in saying 58 abnormal histopathology
specimens as abnormal and 16 normal aortic tissue sections as
normal, the Kappa value is 1.00. The risk factors for these his-
topathologic changes in this study population have been enu-
merated in detail in our previous publication and are not
repeated here.10
Relationship Between Aortic Root Dilatation and
Other Candidate Variables Including ‘‘Exonic DNA
Sequence Variants’’ and Histologic Abnormalities
Aortic diameter measured echocardiographically in our study
showed significant dilatation in 68.9% of patients (n 5 51)
Figure 1. ROC of the study group to compare the tradeoffs between
the true-positive rate and the false-positive rate of low lamellar
count. A lamellar count of 55 as the optimal cutoff point for aortic
dilatation in patients undergoing intracardiac repair with a sensi-
tivity of 78.4% and specificity of 73.9%.tember 2008
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and aortic root dilatation in TOF, aorta with and without
histologic abnormalities, patients with and without fibrillin-
1 ‘‘exonic DNA sequence variants,’’ and other candidate
variables were taken into consideration (Table E3).
Aortic tissue specimens without histologic abnormalities
(n 5 16) were defined as normal and used as the control
group. Of 51 patients with aortic dilatation, 49 (96%) ex-
hibited histologic abnormalities and 26 (51%) exhibited ‘‘ex-
onic DNA sequence variations’’ involving the fibrillin-1 gene
in 1 or more chromosomes (exons 25–28). Some 27 of 28 pa-
tients (96.5%) with genetic abnormalities exhibited abnormal
histopathology of the aortic media (Tables E2 and E3).
It is noteworthy that 96.4% of patients with elastic frag-
mentation (P 5 .003), 78.6% of patients with increased
ground substance (P5 .005), 67.8% of patients with medio-
necrosis (P 5 .017), 53.6% of patients with muscle disarray
(P 5 .017), and 78.6% of patients with fibrosis (P 5 .015)
exhibited ‘‘exonic DNA sequence variations’’ involving the
fibrillin-1 gene in 1 or more chromosomes (exons 27 and
28) (Table E3).
Of 28 patients with fibrillin-1 ‘‘exonic DNA variants,’’ 19
(67.9%) were aged more than 96 months, 24 (85.7%) were
male, 22 (78.6%) had systemic arterial desaturation
(,80%), 22 (78.6%) had a hematocrit level greater than
45%, 24 (85.7%) had aortic override greater than 50%, 19
(67.8%) had MAPCAs, 13 (46.4%) had right aortic arch,
and 21 (75%) had low lamellar count (,55) (Table E3).
The presence of elastic fragmentation, increased ground
substance, medionecrosis, muscle disarray, fibrosis, age
more than 96months, male sex, systemic arterial desaturation
(,80%), hematocrit level greater than 45%, aortic override
greater than 50%, presence of aortic regurgitation, MAPCAs,
higher right ventricular end-diastolic pressure (.12 mmHg),
right aortic arch, DORV, TOF with pulmonary atresia, and
previous systemic-to-pulmonary-artery-shunting procedures
were independent risk factors for aortic root dilatation
according to bivariate analysis (Table E2).
Logistic regression analysis identified histopathologically
abnormal aorta, elastic fragmentation, increased ground sub-
stance, male sex, degree of aortic override greater than 50%,
and DORV as the predictors for aortic dilatation in this study
(Table E4). The risk of aortic dilatation was 8.83 times
greater (95% CI, 1.94–39.99) in patients with histopatholog-
ically abnormal aorta and 8.11 times (95% CI, 1.93–34.04)
greater in patients with ‘‘exonic DNA variants’’ involving
the fibrillin-1 gene (Table E4).
Logistic Regression Analyses of the Association
Between Patients with Fibrillin-1 Genetic
Abnormalities and Aortic Dilatation in the Study
Population (n 5 74)
It is noteworthy that in logistic regression analysis, the associ-
ation between ‘‘exonic DNA sequence variants’’ and aortic di-The Journal of Tholatation showed a significant relationship with an OR of 10.92
(95% CI, 2.31–51.49). The OR remained significant while ad-
justing for age (6.87 [95% CI, 1.33–35.49; P 5 .02]) and for
age, increased ground substance, MAPCAs, abnormal lamel-
lar count (9.85 [95% CI, 1.03–94.22; P 5 .04]).
The adjustment for differences in age, medionecrosis,
MAPCAs, abnormal lamellar count, and for differences in
age, muscle disarray, MAPCAs, and abnormal lamellar count
resulted in a moderate weakening of the OR to 6.49 (95% CI,
0.99–42.26; P 5 .05) and 6.38 (95% CI, 0.98–41.50; P 5
.05), respectively.
The relationship between DNA sequence variation and
aortic dilatation became even weaker when adjusted for age
and abnormal histopathology to 4.59 (95% CI, 0.77–
27.53). The adjustment for age, elastic fragmentation, pres-
ence of MAPCAs, abnormal lamellar count, and for age,
fibrosis, presence of MAPCAs, and abnormal lamellar count
increased the OR to 3.93 (95% CI, 0.53–28.97) and 4.96
(95% CI, 0.58–42.93), respectively, although both were non-
significant (Table E5).
Relationship Between Lamellar Count and Aortic
Dilatation in Tetralogy of Fallot
Analysis of the ROC curve. The mean lamellar count in
this cohort with and without histologic abnormalities (control
group) was 37.3 6 8.7 (range 15-51, median 39.5) and 63.5
6 6.3 (range 55–75, median 61.5), respectively (Figure 1).
By pairwise comparisons, the differences in lamellar count
of both groups of patients were statistically significant
(P , .0001).
A mean lamellar count of 37.3 (68.7, range 15–52) was
always associated with a histologically abnormal aorta and
aortic dilatation (OR 5 0.80 [95% CI, 0.68–0.91];
P , .0001).
With a lamellar count of 55 as the optimal cutoff point for
abnormal aortic histopathology in patients undergoing intra-
cardiac repair of TOF, the sensitivity was 78.4% and the
specificity was 73.9%. The predictive accuracy of a positive
or negative result was 86.9% and 60.7%, respectively. Area
analysis under the ROC curve indicated that 80.1% (standard
error 6 0.06; 95% CI, 0.68–0.92) of the time, the values of
lamellar count were lower for patients with aortic dilatation
in patients undergoing intracardiac repair of TOF compared
with abnormal histopathology, which is highly significant
(P , .001) (Figure 1).
Genetic Mutation Analysis
We identified the following changes on PCR amplification
and SSCP analysis:
Control samples (52 healthy subjects; 104 reference
alleles) from the general population
 There were no shifts in the SSCP gels for exons 24, 25,
26, and 27 on any control samples.racic and Cardiovascular Surgery c Volume 136, Number 3 761
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control samples had S1 type of shift. All shifts were
observed on the non-encoding regions of the genome
(intronic) variants and thus were biologically insignif-
icant.
Samples from patients undergoing intracardiac repair of
TOF:
 There were no shifts in the SSCP gels for exon 24
(Figure 2, A).
 In exons 25 and 26, there were 5 shifts. All shifts were
observed in the same patients. On sequencing of exons
25 and 26, we detected 6 base pair deletions ([del
TCTTTA] [3341 1 55]) in the intron area of 25 and
there were no changes in the exons (Figure 2, B andC).
 In exon 27, 5 similar kind of shifts were observed in 5
patients. Sequencing showed a substitution change
(c.3575C,G) in the exonic region of exon 27 of the
fibrillin-1 gene leading to a change in amino acid
sequence (p.P1148A) (Figure 2, D). This was reported
earlier as mutation and later confirmed as polymor-
phism.
 Exon 28 exhibited a number of shifts in SSCP analysis
on 28 patients. Sequencing revealed 2 different dele-
tions on 2 patients in the intron of exon 28. The first
deletion (del ATTTTT) of 6 base pairs was far (.50
base pairs) from the exon 28. The second deletion of
5 base pairs (del TTATG) was toward the acceptor
site (9 base pairs) (Figure 2, E).
 The rest of the samples did not show any sequence
change.
Discussion
To our knowledge, there are no studies in the English lan-
guage literature addressing specifically the relationship of
‘‘DNA sequence variants’’ involving the fibrillin-1 gene
with aortic dilatation in the presence of intrinsic aortopathy
involving the ascending aorta in TOF.
We studied 5 exons of the fibrillin-1 gene in patients with
TOF and aortic root dilatation. These 5 exons (24–28) were
chosen because most mutations in Marfan syndrome have
been reported in these cases.12-16
The first important finding of this study is the occurrence
of aortic dilatation in 69% of patients before undergoing in-
tracardiac repair of TOF. The second important finding of
this study is the occurrence of significant lamellar loss (lamel-
lar count ,55), abnormal histopathology, and fibrillin-1
‘‘DNA sequence variants’’ in 78.4% (40/51), 96% (49.51),
and 50.9% (26/51) of patients, respectively, with aortic
dilatation undergoing intracardiac repair of TOF. The third
important finding of this study is the significant loss of lamel-
lar counts and the prevalence of intrinsic abnormal histopa-
thology of the aortic wall, including elastic fragmentation
and disruption in patients as early as 6 months of age.762 The Journal of Thoracic and Cardiovascular Surgery c SepAortic Dilatation, Lamellar Loss, Abnormal
Histopathology, and Fibrillin-1 ‘‘DNA Sequence
Variants’’ in Tetralogy of Fallot
Analysis of the published literature documents up to a 15%
incidence of aortic root dilatation in patients undergoing
intracardiac repair of TOF.1-4 The aortic root dilatation is at
times progressive, necessitating aortic valve or aortic root
surgery and has been reported to occur in unoperated and op-
erated patients late after repair.1-9 In the Mayo Clinic series,
the largest aortic root measured was 85 mm in diameter with-
out dissection.2 The literature documents 2 isolated reports of
aortic dissection with aortic root diameters of 6.45 cm27 and
6.1 cm.28
In this study, 69% of patients (n 5 51) undergoing intra-
cardiac repair of TOF demonstrated aortic root dilatation be-
fore surgical repair. The degree of aortic regurgitation in this
study population was mild and of no clinical consequence.
Six variables have been found to potentially influence
aortic dilatation: 1) abnormal morphogenesis resulting in un-
equal division of the fetal truncus, favoring aorta; 2) migra-
tion of the neural crest cells into the cardiac outflow tract,
influencing medial degeneration; 3) volume overload implicit
in the biventricular aorta; 4) aortic regurgitation that creates
volume overload and introduces pulsatile flow facilitating di-
latation; 5) intrinsic medial degenerative changes; and 6)
increased or premature destruction of extracellular matrix
proteins (ie, elastic fibers).1-10,29,30 In operated patients
with TOF, the cause of aortic root dilatation is thought to
be predominantly secondary to chronic hemodynamic stress
from volume overload of the aorta.
It is noteworthy that of these 51 patients with dilated aorta,
49 (96%) exhibited histologic abnormalities and 2 (4%) were
histologically normal. It is hypothesized that this intrinsic
abnormality may be programmed cell death or an expression
of a thus far unrecognized genetic defect involving the cellu-
lar function in the aortic media of patients with TOF.4,6-8,26
Logistic regression analysis of this study, including our
previous publication accounting for the effects of other
variables, demonstrated a relationship between aortic root
dilatation and male sex, aortic override greater than 50%,
presence of DORV, elastic fragmentation, increased ground
substance, and presence of fibrillin-1 ‘‘DNA sequence varia-
tions.’’10 The risk of aortic dilatation was 8.83 times (95%CI,
1.94–39.99, P5 .005) greater in patients with histologically
abnormal aorta and 8.11 times (95% CI, 1.93–34.04, P 5
.004) greater in patients with exonic fibrillin-1 DNA variants
(Tables E2, E4, and E5).
There was a statistically significant interrelationship be-
tween lamellar loss and appearance of abnormal histopathol-
ogy. A mean lamellar count of 37.3 was always associated
with a histologically abnormal aorta and aortic dilatation
(OR 0.80; 95% CI, 0.68–0.91; P , .001). A lamellar count
of less than 55 was associated with a sensitivity of 78.4%
and a specificity of 73.9%. The predictive accuracy oftember 2008
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Da positive or negative result was 86.9% and 60.7%, respec-
tively. Area analysis under the ROC curve indicated that
80.1% (standard error6 0.06) of the time the value of lamel-
lar count was lower for the abnormal histopathology group
compared with the normal histopathology group (Table E3,
Figure 1).
A total of 21 of 28 patients (75%) with fibrillin-1 ‘‘DNA
sequence variants’’ had a lamellar count less than 55 (range,
15–55). These genetic abnormalities may influence the
appearance of histopathologic changes in the aortic wall of
patients with TOF as mentioned above. These histologic ab-
normalities possibly reduce the cohesive and tensile strength
of the media and suggest an important causative mechanism
for aortic root dilatation.
Relationship Between Patients With and Without
Fibrillin-1 Exonic DNA Sequence Variants and
Tetralogy of Fallot
Underlying this tendency to aortic root dilatation are histo-
pathologic changes in the aortic media of the dilated aortic
root that resemble those observed in both bicuspid aortic
valve disease and Marfan syndrome.11,12 The genetic basis
of Marfan syndrome, ectopia lentis, and associated connec-
tive tissue disorders have recently been classified, with muta-
tions of the fibrillin-1 genes being responsible for most
cases.13-16
Fibrillin is a 350-kd glycoprotein that is the major compo-
nent of the 12-mm extracellular microfibrils that act as a net-
work for elastin deposition and is a constituent of the elastic
fiber. The fibrillin-1 gene is a component of microfibrils asso-
ciated with elastic fibers. These microfibrils form a scaffold
for deposition and aggregation of elastin, and the defect in
their synthesis leads to structural weakness of the vascular
walls. It is found preferentially in elastic tissue (eg, tunica
media of aorta), and defects in its expression result in abnor-
mal elastic fibers that lead to skeletal and cardiovascular
anomalies in Marfan syndrome.13-16
The fibrillin-1 gene mutations in Marfan syndrome are
normally clustered in the region of exons 24 to 28. Mutations
in the fibrillin-2 gene have also been implicated in the path-
ogenesis of Marfan syndrome.13-16 The gene abnormalities
include a wide range of point mutations, repeats, deletions,
premature stop codons, and so forth. The genetic abnormali-
ties in Marfan syndrome produce a wide range of results,
ranging from virtually all the fibrillin being the mutant type
to individuals with less than 10% mutant fibrillin, the rest
being the wild type. This results in a huge phenotypic range
of severity.13-16
We confined our search to exons 24 to 28 on the basis of
the clustering of abnormalities in these exons in patients with
Marfan syndrome. Characteristics of these patients with
dilated aortic root and gene polymorphs compared with con-
trols included older age at repair (.96 months), presence of
MAPCAs, right aortic arch, degree of aortic override greater764 The Journal of Thoracic and Cardiovascular Surgery c Septhan 50%, a higher prevalence of abnormal aortic histopa-
thology (ie, elastic fragmentation), increased ground sub-
stance, medionecrosis, fibrosis, and an abnormally low
lamellar count (,55) (Table E3).
In this study, 5 patients with TOF showed a substitution
change (c.3575C,G) located in exon 27, which led to
a change in protein sequence (p.P1148A). This was reported
earlier as mutation and later confirmed as polymorphism.
Thus, the combination of exonic changes in the same patients
on exons 27 and 28 and patients with polymorphism may
have a causative role in aortic dilatation. This study did not
demonstrate any point mutations, repeats, deletions, or pre-
mature stop codons in fibrillin-1 gene on exons 25 to 28.
However, it revealed a combination of exonic changes in
the same patients on exons 27 and 28 and polymorphism in
a subset of patients.
It is noteworthy that 96.4% of patients with elastic
fragmentation (P 5 .003), 78.6% of patients with increased
ground substance (P5 .005), 67.8% of patients with medio-
necrosis (P 5 .017), 53.6% of patients with muscle disarray
(P 5 .017), and 78.6% of patients with fibrosis (P 5 .015)
exhibited ‘‘exonic DNA sequence variations’’ involving the
fibrillin-1 gene in 1 or more chromosomes (exons 27 and
28) (Table E3).
It is pertinent to state that in logistic regression analysis,
the association between ‘‘exonic DNA sequence variants’’
and aortic dilatation showed a significant relationship with
an OR of 10.92 (95% CI, 2.31–51.49). The OR remained
significant while adjusting for age (6.87 [95% CI, 1.33–
35.49; P 5 .02]), and for age, increased ground substance,
MAPCAs, and abnormal lamellar count (9.85 [95% CI,
1.03–94.22; P 5 .04]).
The adjustment for differences in age, medionecrosis,
MAPCAs, abnormal lamellar count, and for age, muscle dis-
array, MAPCAs, and abnormal lamellar count resulted in
a moderate weakening of the OR to 6.49 (95% CI, 0.99–
42.26; P 5 .05) and 6.38 (95% CI, 0.98–41.50; P 5 .05),
respectively.
The relationship between DNA sequence variation and
aortic dilatation became even weaker when adjusted for age
and abnormal histopathology: 4.59 (95% CI, 0.77–27.53).
The adjustment for age, elastic fragmentation, presence of
MAPCAs, abnormal lamellar count, and for age, fibrosis,
presence of MAPCAs, and abnormal lamellar count in-
creased the OR to 3.93 (95% CI, 0.53–28.97) and 4.96
(95% CI, 0.58–42.93), respectively, although both were non-
significant (Table E5).
Study Limitations
We recognize that our study has limitations. This study was
designed on the assumption that the nature and frequency
of mutations in Marfan syndrome in Indians are not different
from that found in the Caucasian population. In the absence
of data regarding mutation in Marfan syndrome and TOFtember 2008
Chowdhury et al Surgery for Congenital Heart Diseasein the Indian population, this assumption remains unvali-
dated.
We found significant heterogeneity of clinical characteris-
tics, such as age, gender, and other variables, including aortic
diameter, between patients with normal and dilated aortas,
which may have affected the results.
Our study has not investigated genetic abnormalities on
other exons or abnormalities, such as neural crest markers
and 22q.11 deletion in TOF. Our study illustrates that the mu-
tations in exons 24 to 28 (the region of clustering of muta-
tions in Marfan syndrome) of fibrillin-1 gene are not
common in TOF. Whether mutations in other exons are com-
mon in TOF and their relationship (if any) in causing aortic
dilatation need to be explored. The frequency of chromosome
22q11.2 deletion by fluorescence in situ hybridization, occur-
rence of fibrillin-2 gene mutations, and transcription factor
NKX 2.5 mutations (if any) in TOF with or without aortic
dilatation are being explored.
Although SSCP analysis is the most commonly used
method for screening, it has the following drawbacks: 1)
The sensitivity varies from 60% to 80%, depending on the
gene to be analyzed, primer pairs used, and quality of tissue
examined; thus, the investigator may miss a significant num-
ber of base changes. 2) Small gene segments, ranging from
150 to approximately 300 base pairs in length, can be
screened only with SSCP. Larger genes will require multiple
sets of primers and PCR products to cover the entire gene. 3)
The sequence context and actual base substitution can influ-
ence the sensitivity of the assay, making it difficult to thor-
oughly standardize the assay for the entire gene sequence.23
Although allele-specific oligonucleotide hybridization
analysis is a quick and simple way to screen for polymor-
phisms and mutations in specific gene sequences, a disadvan-
tage of this technique is excess time consumption on
screening more than 1 or 2 bases.23
Other intermediate screening platforms, such as denatur-
ing high performance liquid chromatography, denaturing
gradient gel electrophoresis, conformation sensitive gel elec-
trophoresis, and heteroduplex analysis have the potential to
offer increased sensitivity, ranging from 80% to 99% and
allow for analysis of larger fragments.21,23
In addition, denaturing high performance liquid chroma-
tography screening is costly and more useful for a pilot study.
Conformation sensitive gel electrophoresis also has 80% to
90% sensitivity but cannot differentiate between homozy-
gous and heterozygous changes. Thus, in deciding on the ap-
propriate post-PCR analytic techniques, both the advantages
and drawbacks of each technique should be taken into con-
sideration.21,23
Conclusions
Our findings indicate that the majority of aortic media of the
ascending aorta in cyanotic TOF exhibit a significant loss of
lamellar units and preexisting intrinsic aortopathy. An in-The Journal of Thorcreased incidence of ‘‘exonic DNA variants’’ involving the
fibrillin-1 gene in 1 or more chromosomes (exons 27 and
28) were noted in cyanotic TOF with dilated aorta in the pres-
ence of abnormal histopathology. These genetic abnormali-
ties may account for or coexist with the higher incidence of
aortic dilatation observed in these patients. On the basis of
these results, at a minimum, we recommend screening for
the above-mentioned genes along with larger-scale histopath-
ologic studies of the aorta commencing in infancy.
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TABLE E1. Demographic, operative, and postoperative
details of the study group
Patient-related variables Mean 6 SD (range)
Age at operation (mo) 112.6 6 104.52 (6 mo to 45 y;
median, 80 mo)
Age ,96 mo 41
.96 mo 33
Male : Female 52 : 22
Weight at operation (kg) 25.50 6 12.80 (2.5–72;
median, 17 kg)
Body surface area (m2) 0.92 6 0.28 (0.19–1.8;
median 0.82 m2)
Previous Blalock-Taussig shunt 25






,12 mm Hg 57





Coil embolization of MAPCAs 33













TOF with pulmonary stenosis 39
DORV (Fallot type) and TOF
with pulmonary atresia
35




Intact pulmonary annulus 20
Limited transannular patch 51




Aortic crossclamp time (min) 40.0 6 12.0














MAPCA, Major aortopulmonary collateral artery; SD, standard deviation;
TOF, tetralogy of Fallot; DORV, double outlet right ventricle; LV, left ventricle;
PA, pulmonary artery; RV, right ventricle.
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TABLE E2. Odds ratio for potential risk factors for aortic dilatation in patients undergoing intracardiac repair of tetralogy
of Fallot (bivariate analysis) (n 5 74)
Aortic dilatation (n 5 51)
S. No. Variables No. No. OR ratio (95% CI) P value
1. Aortic wall histology
 Abnormal 58 49 38.11 (7.37–197.11) ,.001
 Normal control 16 2
2. Elastic fragmentation
 Present 58 49 38.11 (7.37–197.11) ,.001
 Absent 16 14
3. Increased ground substance
 Present 43 40 24.24 (6.07–96.83) ,0.001
 Absent 31 11
4. Medionecrosis
 Present 37 31 4.39 (1.48–13.03) .006
 Absent 37 20
5. Muscle disarray
 Present 27 23 3.90 (1.16–13.09) .02
 Absent 47 28
6. Fibrosis
 Present 45 40 13.09 (3.96–43.23) ,.001
 Absent 29 11
7. Age
 .96 mo 33 31 16.27 (3.43–77.10) ,.001
 , 96 mo 41 20
8. Sex
 Male 52 44 11.78 (3.65–38.03) ,0.001
 Female 22 7
9. Systemic arterial oxygen saturation
 ,80% 43 37 7.48 (2.45–22.85) ,.001
 .80% 31 14
10. Hematocrit
 .45% 48 37 2.88 (1.03–8.03) .04
 ,45% 26 14
11. Aortic override
 .50% 42 40 38.18 (7.73–188.46) ,.001
 ,50% 32 11
12. Aortic regurgitation
 Yes 13 12 6.77 (0.82–55.60) .04
 No 61 39
13. MAPCAs
 Present 33 27 5.34 (1.59–17.93) .004
 Absent 43 24
14. Previous palliation
 Yes 25 20 2.32 (0.74–7.25) .11
 No 49 31
15. Right ventricular end-diastolic pressure
 .12 mm Hg 17 16 10.06 (1.24–81.27) .008
 ,12 mm Hg 57 35
16. Right aortic arch
 Yes 21 19 6.23 (1.31–29.59) .009
 No 53 32
17. Diagnosis
 TOF with PS 39 20 0.13 (0.04–0.46) ,.001
 DORV, TOF with PA 35 31
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TABLE E2. Continued
Aortic dilatation (n 5 51)
S. No. Variables No. No. OR ratio (95% CI) P value
18. Lamellar count
 Abnormal (mean 6 SD 37.3 6 8.7; range 15–51) 46 40 6.75 (1.65–27.58) .008
 Normal (mean 6 SD 63.5 6 6.3; range 55–75) 28 11
19. Fibrillin-1 exonic DNA variants
 Yes 28 26 10.92 (2.31–51.49) .003
 No 46 25
OR, Odds ratio; CI, confidence interval;MAPCA, major aortopulmonary collateral artery; TOF, tetralogy of Fallot; PS, pulmonary stenosis; DORV, double outlet
right ventricle; PA, pulmonary artery; SD, standard deviation.
The authors are grateful to Mr. Shanker Sharma for preparation of the manuscript.
Chowdhury et al Surgery for Congenital Heart Disease
CH
D
The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 3 766.e3
TABLE E3. Relationship between patients with and without ''DNA sequence variants'' with other risk factors for aortic
dilatation in the study population (n 5 74)
Fibrillin-1 exonic DNA variants
S. No. Variables Present (%) Absent (%) P value
1. Elastic fragmentation (n 5 58)
 Present 27 (96.4) 31 (67.4) .003
 Absent 1 (3.6) 15 (32.6)
2. Increased ground substance (n 5 43)
 Present 22 (78.6) 21 (45.6) .005
 Absent 6 (21.4) 25 (54.4)
3. Medionecrosis (n 5 37)
 Present 19 (67.8) 18 (39.1) .017
 Absent 9 (32.2) 28 (60.9)
4. Muscle disarray (n 5 27)
 Present 15 (53.6) 12 (26.1) .017
 Absent 13 (46.4) 34 (73.9)
5. Fibrosis (n 5 45)
 Present 22 (78.6) 23 (50) .015
 Absent 6 (21.4) 23 (50)
6. Age
 .96 mo 19 (67.9) 14 (30.4) .002
 ,96 mo 9 (32.1) 32 (69.6)
7. Sex
 Male 24 (85.7) 28 (60.9) .023
 Female 4 (14.3) 18 (39.1)
8. Systemic arterial oxygen saturation
 ,80% 22 (78.6) 26 (56.5) .05
 .80% 6 (21.4) 20 (43.5)
9. Hematocrit
 .45% 22 (78.6) 26 (56.5) .05
 ,45% 6 (21.4) 20 (43.5)
10. Aortic override
 .50% 24 (85.7) 18 (39.1) ,.001
 ,50% 4 (14.3) 28 (60.9)
11. Aortic regurgitation
 Yes 8 (28.6) 5 (10.9) .05
 No 20 (71.4) 41 (89.1)
12. MAPCAs
 Present 19 (67.8) 12 (26.1) ,.001
 Absent 9 (32.2) 34 (73.9)
13. Previous palliation
 Yes 14 (50) 11 (23.9) .02
 No 14 (50) 35 (76.1)
14. Right ventricular end-diastolic pressure
 .12 mm Hg 10 (35.7) 7 (15.2) .04
 ,12 mm Hg 18 (64.3) 39 (84.8)
15. Right aortic arch
 Present 13 (46.4) 8 (17.4) .007
 Absent 15 (53.6) 38 (82.6)
16. Diagnosis
 TOF, PS 11 (39.3) 28 (60.9) .07
 DORV, PS 17 (60.7) 18 (39.1)
17. Histopathology (n 5 58)
 Abnormal (n 5 58) 27 (96.4) 31 (67.4) .003
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TABLE E3. Continued
Fibrillin-1 exonic DNA variants
S. No. Variables Present (%) Absent (%) P value
 Normal (n 5 16) 1 (3.6) 15 (32.6)
18. Lamellar count
 ,55 21 (75) 25 (54.4) .007
 .55 7 (25) 21 (45.6)
TOF, Tetralogy of Fallot; PS, pulmonary stenosis; DORV, double outlet right ventricle.
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TABLE E4. Predictors of aortic dilatation by stepwise logistic regression analysis applied to all 74 patients
Variables (covariates adjusted) OR (95% CI) P value
1. Histopathologically abnormal aorta 8.83 (1.94–39.99) .005
2. Elastic fragmentation 8.83 (1.94–39.99) .005
3. Increased ground substance (n 5 53) 9.65 (1.97–47.34) .005
4. Male sex 26.11 (4.03–169.20) .001
5. DORV 7.61 (1.26–46.12) .003
6. Aortic override .50% 6.75 (1.65–27.58) .008
7. Fibrillin-1 exonic DNA variants 8.11 (1.93–34.04) .004
OR, Odds ratio; CI, confidence interval; DORV, double outlet right ventricle.
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TABLE E5. Logistic regression analyses of the association between patients with fibrillin-1 ''exonic DNA sequence
variants'' and aortic dilatation in the study population
DNA sequence variants
(absent, n 5 46)
DNA sequence variants
(present, n 5 28)
Normal aorta (n 5 23) DNA
sequence variants (1) (n 5 2)
Dilated aorta (n 5 51) DNA
sequence variants (1) (n 5 26)
OR OR (95% CI) P value
Unadjusted 1.0 10.92 (2.31–54.49) .003
Adjusted for
Age 1.0 6.87 (1.33–35.49) .02
Age and abnormal histopathology 1.0 4.59 (0.77–27.53) .09
Age, presence of elastic fragmentation, MAPCAs,
and abnormal lamellar count
1.0 3.93 (0.53–28.97) .18
Age, presence of increased ground substance,
MAPCAs, and abnormal lamellar count
1.0 9.85 (1.03–94.22) .04
Age, presence of medionecrosis, MAPCAs, and
abnormal lamellar count
1.0 6.49 (0.99–42.26) .05
Age, presence of muscle disarray, MAPCAs, and
abnormal lamellar count
1.0 6.38 (0.98–41.50) .05
Age, presence of fibrosis, MAPCAs, and
abnormal lamellar count
1.0 4.96 (0.58–42.23) .14
OR, Odds ratio; CI, confidence interval; MAPCA, major aortopulmonary collateral artery.
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TABLE E6. Histologic definitions and grading of tunica media sections of the aortic wall
Histology Grade 1 Grade 2 Grade 3
Medionecrosis
Focal loss of smooth
muscle cell nuclei media
Focal loss consisting of ,1/3
of total width of media
Focal loss consisting of 1/3
to 2/3 of media thickness





Fibrosis in ,1/3 of total width
of media or focal accumulation
throughout
Fibrosis in 1/3 to 2/3 of total
width of media with multiple
small areas of fibrosis
Fibrosis in.2/3 of total width of
media with multiple small
areas of fibrosis
Cystic medial necrosis (mucoid accumulation)
Cysts are observed in
presence of intact elastic
lamellae and fragmented
elastic fibers
Minute foci within a single lamellar
unit not encompassing its
entire width
Increased size and No. of
''cysts'' plus mucoid material
covering the total width of 1
lamellar unit
Large and extended ''cysts''





elastic lamellae in aortic
media
,5 foci of elastic lamellae
fragmentation in 1 microscopic
field of 3200
5 to 9 foci of elastic lamellae
fragmentation in 1
microscopic field of 3200
$10 foci of elastic lamellae
fragmentation in 1
microscopic field of 3200
Elastic lamellae Total No. of elastic lamellae in media were
counted. Median value in different age
groups was used as the ''cutoff'' value
to differentiate normal from abnormal
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I 24 Forward 5'-CAGCAAATTATTATGTGTGCAG 418 60
Reverse 5'- ATCAAGTAGAGTGCTGAGATC
II 25 Forward 5'-CAAGAACTTCCAACCTTCATG 313 60
Reverse 5'-ACAGCCTTAATTCTTGCGACA
III 26 Forward 5'-CTTAAGGGCCAGGAGAGGG 321 60
Reverse 5'-ACCTGGAACATAGGCTATGAG
IV 27 Forward 5'-GGAGGAGTGCTTGGTCTGG 276 60
Reverse 5'-CAAACATAAGCTTCCAACTTTGGC
V 28 Forward 5'-CGTGTATCGGTAAGGAGAAAGAC 373 55
Reverse 5'-ACAAAACTCAGAGTACATAGAG
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TABLE E8. Single-strand conformation polymorphism
analysis of the amplified products to identify sequence
alterations
Sequence alteration Amino acid alteration Exon
3037 G to A G 101 3R 24
3069 G to C K 1023 N 24
3174INS 3 1058 ins C 25
3217 G to A E 1073 K 26
3220 T to C C 1073 K 26
3350 G to A C 1074 R 27
3410 G to C C 1117 Y 27
3464 del 17 Frameshift 28
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